Shankar Biswas, Yashasvi Srivastava, Rahul Falodia, Ayman Hamadttu. "Real-world comparative safety of first-line lorlatinib versus alectinib in metastatic ALK-rearranged non-small cell lung cancer: A propensity score-matched analysis.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.19_suppl.283